(TS)

(Bloomberg) — Regardless of what typical Americans think about the Patient Protection and Affordable Care Act (PPACA), investors in U.S. Treasuries think the law is reining in health care costs.

After doubling in the past two decades, medical expenses rose less last year than at any time since Harry S. Truman was president in 1949, helped by Medicare reimbursement cuts.

The rollout of PPACA hold down consumer prices for years, BNP Paribas SA. and Credit Suisse Group A.G. said.

Less inflation, which boosts the purchasing power of fixed-rate payments, may help attract buyers to Treasuries as the economy strengthens and the Federal Reserve pares its own bond buying.

While yields have fallen this year, the compensation 10-year notes provide after inflation is close to the highest in five years.

Excluding the effects of changes in the cost of food and energy, inflation has risen just 1.1 percent in the past 12-month period, down from 2 percent in the previous 12-month period.

Growing stability in health care costs accounted for one-third of the drop in what the Fed thinks of as the core inflation rate.

“This is good news” for bonds, Kathy Jones, a fixed-income strategist at Charles Schwab & Co., said in a telephone interview. By holding costs down, “it may be a benefit to inflation, longer-term.”

Jones, who has been advising clients on the bond-market implications of PPACA, is recommending that investors buy 10-year Treasuries because low inflation will keep the Fed from lifting interest rates.

Costs for medical care increased just 2 percent last year. That’s the smallest gain in 65 years, according to data compiled by the U.S. Labor Department.

Price increases eased as Medicare reimbursements were cut under last year’s budget sequestration and Americans gained access to more generic drugs.

In the two decades before the financial crisis, health-care expenses rose at more than twice that rate on an annual basis.

The slowdown in medical expenses has helped curb inflationary pressures, with living costs rising 1.48 percent in 2013, the least during an expansion in 39 years.

“Inflation is already very low, so having one more category that lowers it even more makes nominal Treasuries even more attractive,” Aaron Kohli, an interest-rate strategist at BNP Paribas, one of 22 primary dealers that trade with the Fed, said in a telephone interview.

Consumer prices in March rose 1.5 percent from a year earlier and increased 0.2 percent from the previous month, according to government data released today.

Using the Fed’s preferred gauge of inflation, known as the personal consumption expenditures deflator, or PCE, health care is having an even greater impact on efforts to contain prices.

Because medical spending accounts for 17 percent of PCE inflation, slower growth in health care costs may delay the Fed’s eventual move to lift interest rates, said Martin Hegarty, the head of inflation-linked bond portfolios at BlackRock Inc..

“PCE is going to be lower,” Hegarty said by telephone.

Inflation has remained below the Fed’s 2 percent target for 22 straight months and “a couple” of policy makers said at its March meeting that unusually slow growth in health-care prices has played a “notable role” in holding back prices, minutes of the gathering show.

February’s 1.1 percent core PCE matched January as the lowest since March 2011. Including food and energy, inflation was even weaker, eased to 0.9 percent from a year ago.

While forecasters predicted yields on 10-year Treasuries would rise this year to end at 3.44 percent, borrowing costs have fallen even as the Fed began curtailing its stimulus after spending more than a half-trillion dollars buying U.S. debt in 2013. Yields on the 10-year note decreased from a 29-month high of 3.05 percent in January to 2.65 percent yesterday.

Although that level is almost 2 percentage points below the two-decade average, they still offer returns that are close to the highest since 2009 relative to inflation. Real yields are now 1.78 percentage points higher than PCE, versus 1.21 percentage points on average in the past five years.

Some bond investors are already paring back their inflation expectations. Based on the gap between yields of fixed-rate Treasuries due in 2019 and inflation-linked notes of the same maturity, traders anticipate consumer prices will rise an average 1.81 percent annually over the next five years.

“The ACA is a very important driver” of lower prices and is helping create disinflationary expectations, Carlos Pro, an interest-rate strategist at Credit Suisse Group AG, said.

Health-care costs and Obamacare have been one of the main themes of Pro’s discussions with clients since July.

Some investors may be overestimating the benefits of “Obamacare” on future price gains as an aging U.S. population pushes up health-care spending and costs over time, according to Michael Pond, the head of global inflation-linked research at Barclays P.L.C.

The absence of a sequestration effect should also ease downward pressure on health costs, Pond said.

But Tony Wong, a fixed-income analyst at Invesco Ltd., expects recent price trends to continue.

 “There are some structural factors that over the medium- term will exert a lot of downward pressure on health-care inflation,” Wong said by telephone.

–With assistance from Cordell Eddings in New York.

See also:

Copyright 2018 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.